Related Articles
Epigenetic inactivation of PLCD1 in chronic myeloid leukemia
Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cells
Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients
Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia